FALL 

ADVANCED EDUCATION PRESENTED BY AND FOR NPs AND PAs - A CE/CME EVENT

October 28, 2021 – October 30, 2021

ACCREDITATION STATEMENT

[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  [bold]Earn up to[/bold] 9.25 [italic]AMA PRA Category 1 Credit(s)™ [/italic]for this fall session. [bold]For Full Conference Attendance: For Physicians [/bold] Medscape, LLC designates this live event for up to 9.25 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Physician Assistants [/bold] Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.25 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation. [bold]For Nurses[/bold] Up to 9.25 contact hour(s) of nursing continuing professional development for APNs and RNs Nursing; 4.75 contact hours are in the area of pharmacology. [bold]For Single Session Attendance: Session I: Diabetes and Other Critical Considerations For Physicians [/bold] Medscape, LLC designates this live event for a maximum of 2.5 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Physician Assistants [/bold] Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation. [bold]For Nurses[/bold] Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology. [bold]Session II: Diabetes and Non-Glycemic CVD/CKD Risk Reduction For Physicians [/bold] Medscape, LLC designates this live event for a maximum of 2.5 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Physician Assistants [/bold] Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation. [bold]For Nurses [/bold] Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.0 contact hours are in the area of pharmacology. [bold]Session III: Endocrine Case Studies For Physicians [/bold] Medscape, LLC designates this live event for a maximum of 4.25 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Physician Assistants[/bold] Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation. [bold]For Nurses [/bold] Awarded 4.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.5 contact hours are in the area of pharmacology.

LEARNING OBJECTIVES

Upon completion of the fall Metabolic & Endocrine Disease Summit (MEDS 2021) conference series, learners will have

  • Increased knowledge regarding
    • Clinical signs and symptoms of endocrine disorders
    • Patient assessment criteria to diagnose metabolic-and endocrine-related disorders
    • Guideline recommendations and best practices for individualized treatment of metabolic- and endocrine-related disorders
  • Greater competence related to
    • Diagnosing metabolic- and endocrine-related disorders
    • Individualizing treatment in patients with metabolic- and endocrine-related disorders